greeksoup/ stock research
Stock research / United States / JANX / Planned sales

Janux Therapeutics, Inc. planned insider sales

In the last twelve months insiders at Janux Therapeutics, Inc. filed 10 Form 144 notices of planned sales, 514,084 shares worth $7.8 million at the time of filing, from 5 sellers. The latest, filed 2 June 2026: Janeen Noel Doyle (officer), 4,059 shares worth $56,944, planned for around 2 June 2026 through Morgan Stanley Smith Barney LLC.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
2 June 2026Janeen Noel DoyleOfficer4,059$56,9442 June 20264,059 shares from 2 June 2026Morgan Stanley Smith Barney LLCRestricted Stock Units vesting under registered planForm 144
13 April 2026Andy MeyerFormer Affiliate1,877$28,24613 April 2026No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesExercise of options under a registered planForm 144
2 April 2026Zachariah A McIverFormer Officer74,802$1.1 million2 April 2026No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesExercise of options under a registered plan; Restricted stock vesting under a registered planForm 144
26 January 2026Andy MeyerFormer Affiliate178,767$2.6 million26 January 2026No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesExercise of options under a registered planForm 144
23 January 2026Andy MeyerFormer Affiliate118,122$1.7 million23 January 2026No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesExercise of options under a registered planForm 144
15 December 2025Byron C RobinsonOfficer16,666$258,36615 December 2025No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesStock Option ExerciseForm 144
8 December 2025Byron C RobinsonOfficer50,000$826,0008 December 2025No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesStock Option ExerciseForm 144
2 December 2025Byron C RobinsonOfficer63,125$1.0 million2 December 2025No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesStock Option ExerciseForm 144
1 December 2025Andrew MeyerOfficer3,333$113,6221 December 20255,212 shares from 1 December 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
14 November 2025Andrew MeyerOfficer3,333$91,52414 November 20253,333 shares from 14 November 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?